Related Experiment Videos
Chemotherapy-related cognitive dysfunction in breast cancer
1Baylor Sammons Cancer Center, US Oncology, Dallas, TX, USA.
Seminars in Oncology Nursing
|January 2, 2004
Summary
Chemotherapy can cause cognitive dysfunction in breast cancer survivors, potentially due to anemia or direct brain effects. Assessment and management strategies are being explored to help patients cope with these changes.
Area of Science:
- Oncology
- Neuroscience
- Cancer Survivorship
Background:
- Chemotherapy-related cognitive dysfunction (CRCD) is a significant concern for breast cancer survivors.
- Understanding the underlying mechanisms and risk factors is crucial for effective patient care.
Purpose of the Study:
- To review the pathophysiology, risk factors, assessment methods, and management strategies for CRCD in breast cancer survivors.
- To highlight the role of oncology nurses in managing cognitive changes.
Main Methods:
- A review of published biomedical literature was conducted.
- Focus on identifying key aspects of CRCD based on existing research.
Main Results:
- CRCD in breast cancer patients is multifactorial, possibly linked to anemia or direct chemotherapy effects on the brain.
- Clinical observation and patient self-reports are valuable assessment tools.
Conclusions:
- CRCD is a complex condition requiring further investigation into its causes and treatments.
- Oncology nurses play a vital role in monitoring cognitive function and supporting patients and caregivers through education and awareness.